A Pharmacokinetics and Tolerability Study of Fedratinib in Subjects With Moderate and Severe Hepatic Impairment

Clinical trial NCT03983161 · COMPLETED

Trial details

NCT number: NCT03983161
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Hepatic Impairment

Start date: 2019-09-04
Primary completion: 2023-01-05
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.